Abstract
Over the years, the length of stay post-kidney transplantation (post-KT) has significantly reduced, leading to most of the post-KT care in an outpatient setting. With introduction of current immunosuppression rate of early rejection has declined, but inherent side effects in the long term have escalated. Hence, the long-term graft dysfunction and graft loss among post-KT patients have not changed significantly. Furthermore, the new kidney allocation policies and increased use of high kidney donor profile index (KDPI) kidneys have pushed the boundaries further, leading to new challenges in the management of post-KT recipients. These KT recipients, who have already been dealing with problems related to comorbidities prior to KT, now have to face new challenges resulting from the effects of immunosuppression. The type of comorbid illnesses post-KT determines the morbidity, as well as their short- and long-term patient and graft survival outcomes. This chapter summarizes late post-KT medical complications, focusing on the importance of early diagnosis and efficient management of these complications in the outpatient setting in improving outcomes. The goal is to identify causes of graft dysfunction, graft loss, and patient mortality post-KT and to devise strategies to improve patient and graft survival.
This is a preview of subscription content, log in via an institution to check access.
References
Abbud-Filho M, Adams PL, Alberu J et al (2007) A report of the Lisbon Conference on care of kidney transplant recipient. Transplantation 83:S1–22
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roceella EJ (2003) The 7th report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 report. J Am Med Ass 289:2560–2572
Cosio FG, Pesavento TE, Pelletier RP, Henry M, Ferguson RM, Kim S, Lemeshow S (2002) Patients’ survival after renal transplantation. III: the effects of statins. Am J Kid Dis 40(3):638–643
Danovitch GM Medical complications, 5th edn. Handbook of kidney transplantation. LWW 5th edition 2009
Djamali A, Samaniego M, Muth B, Muehrer R, Hofmann RM, Pirsch J, Howard A, Mourad G, Becker BN (2006) Medical care of kidney transplant recipient after first year post transplant year. Cl J Am So Nephrol 1(4):623–640
EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV. 5.2. Cardiovascular risks. Arterial hypertension. Nephrol Dial Transplant 17(Suppl 4):25–26
Fellstrom B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Logan JO, Perdersen TR (2004) Effect of Fluvastatin on renal end points in assessment of Lescol in renal transplant (ALERT) trial. Kidney Int 66(4):1549–1555
Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357:2601–2614
Fishman JA, Rubin RH (1998) Infection in organ transplant recipients. N Engl J Med 338(24):1741–1751
Golgert WA, Appel GB, Hariharan S (2008) Recurrent glomerulonephritis after renal transplantation: an unsolved problem. Clin J Am Soc Nephrol 3(3):800–807
Heaf JG (2003) Bone disease after renal transplantation. Transplantation 75(3):315–325
Jardine AG, Holdaas H, Fellstorm B, Cole E, Nyberg G, Gronhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambuhl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR (2004) Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post hoc subgroup analysis of ALERT study. Am J Transplant 4(6):988–995
Kasiske BL, Vasquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG (2000) Recommendations for outpatient surveillance of renal transplant recipients. American Society of transplantation. J Am Soc Nephrol 11(Suppl 15):S1–S86
Kasiske BL, Snyder JJ, Gilbertson DT, Wang C (2004) Cancer after kidney transplantation in United States. Am J Transplant 4(6):905–913
K/DOQI (2004) Clinical practice guidelines for managing dyslipidemia in kidney transplant recipient patients. Am J Transplant 4(Suppl 7):13–53
KDOQI (2004) Clinical practice guidelines on HTN and anti hypertensive agents in chronic kidney disease. Am J Kid Dis 11–13
Mailloux LU et al (2001) Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes. Semin Nephrol 21(2):146–156. PMID 15167583
Mannon RB (2004) Polyomavirus nephropathy: What have we learned? Transplantation 77(9):1313–1318. PMID 15167583
Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B et al (2004a) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4(3):378–383
Meier-Kriesche HU, Schold JD, Kaplan B et al (2004b) Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4(8):1289–1295
Midvedt K, Hartmann A (2002) Hypertension after kidney transplantation: are treatment guidelines emerging? Nephrol Dial Trasnplant 17:1166–1169
Midvedt K, Hartmannn A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdas H (2001) Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation 72:1787–1792
Morales JM, Marcen R, Castillo D, Andres A, Gonzalez-Molina M, Oppenheimer F, Seron D, Gil-Vernet S, Lampreave I, Gainza FJ, Valdes F, Cabello M, Anaya F, Escuin F, Arias M, Pallardo L, Bustamante J. (2012) Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multi-center study. Nephrol Dial Transplant 27(Suppl 4):39–46
Morath C, Mueller M, Goldschimdt H, Schwenger V, Opelz G, Zeier M (2004) Malignancy in renal transplantation. J Am Soc Nephrol 15:1582–1588
National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1–S201
Opelz G, Dohler B (2005) Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5:2725–2731
Rana A, Gruessner A, Agopian VG, Khalpey Z, Riaz IB, Kaplan B, Halazun KJ, Busuttil RW, Gruessner RW et al (2015) Survival benefit of solid-organ transplant in the United States. JAMA 150(3):252–259
Rodino MA, Shane E et al (1998) Osteoporosis after organ transplantation. Am J Med 104:459–469
Ronco et al. Short- and long- term management after kidney transplantation, 2nd edn. Critical care nephrology. Elsevier 2nd edition 2008
Saifu MO, Tedla F, Markell MS (2005) Management of the well renal transplant recipient: outpatient surveillance and treatment recommendation. Semin Dial 18(6):520–528
Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D et al (2011) Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 11(10):2093–2109
Younas N, Wu CM, Shapiro R, McCauley J, Johnston J, Tan H, Basu A, Schaefer H, Smetanka C, Winkelmayer WC, Unruh M (2010) HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patients or graft survival. BMC Nephrol 11(1):5
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Yadav, A., Gulati, R. (2018). Medical Complications After Kidney Transplantation: Late. In: Ramirez, C., McCauley, J. (eds) Contemporary Kidney Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-14779-6_16-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-14779-6_16-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14779-6
Online ISBN: 978-3-319-14779-6
eBook Packages: Springer Reference MedicineReference Module Medicine